Jaguar health inc.

Major-Pharmaceuticals

JAGX


201 Mission Street
San Francisco , CA 94105

Executive/
Director

Price

  • Last Close
  • $ 0.09
    $ +0 0 %
    Jan 20, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 49,354,560
  • Market Cap Full
  • $ 15.4M
  • Shares Outstanding
  • 171.4M
    May 15, 2018
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - -29.8% 39.7% 39.5% 21.7% -5% 120.9% -26.2% -2.3% -
Q2 -28.9% 16.5% -47.1% -52.7% 1421% 4% -12.2% -62.3% - -
Q3 -32.8% -30.4% -62.2% -36.3% -76.2% 8% 43.7% -46.9% - -
Q4 -30.6% -44.1% -41.3% -72.6% -36.3% 182% -53.5% -44.2% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 -2.3% - - - - - - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%-68%-80%-89%219%11%29%-92%-2%0%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 1.32 0.43 0.28 -0.75 -16.78 -0.56 -0.1 -30.08 -2.39
Q2 0.97 0.35 0.12 -0.76 -15.11 -0.44 -0.1 -9.02 -0.42
Q3 0.36 0.30 0.13 -0.51 -2 -0.21 -0.27 -9.02 -0.38
Q4 - - - -0.17 24.94 0.21 -23.56 11.94 -
A 2.7 1.1 0.5 -2.2 -9 -3 -88.2 -36.2 -3.19

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018
Mar -
Jun 171.4
Sep -
Dec -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.3 0.4 1 2 -
Fixed Asset Turnover 6 4 9 6 0.1
Total Asset Turnover 0.3 0.1 0.2 0.2 0.1
Leverage
Debt Ratio 0.8 0.9 0.7 - -
Debt – Equity Ratio -18 2.1 0.7 - -
Interest Coverage -2.6 -3.4 -3.9 -2.9 -23.3
Equity multiplier -2 0.1 0.1 0.1 0.1